Select Medical reaffirmed earnings guidance for the year 2024. The company expects revenue to be in the range of $6.9 billion to $7.1 billion, fully diluted earnings per share to be in the range of $1.95 to $2.19.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.82 USD | +0.27% | +1.08% | +43.91% |
May. 06 | UBS Adjusts Select Medical Price Target to $34 From $31, Maintains Neutral Rating | MT |
May. 06 | Benchmark Adjusts Price Target on Select Medical Holdings to $42 From $39, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.91% | 4.4B | |
+24.67% | 88.39B | |
-23.73% | 75.6B | |
+3.24% | 26.87B | |
-12.06% | 16.85B | |
-0.02% | 15.31B | |
+75.93% | 13.53B | |
+82.63% | 13.48B | |
-24.56% | 13.01B | |
+23.23% | 12.57B |
- Stock Market
- Equities
- SEM Stock
- News Select Medical Holdings Corporation
- Select Medical Reaffirms Earnings Guidance for the Year 2024